Safety and effectiveness of disease-modifying therapies after switching from natalizumab. - Zeineddine, Maya; Al-Roughani, Raed; Farouk Ahmed, Samar; Khoury, Samia; El-Ayoubi, Nabil; Al-Mahdawi, Akram; Al-Khabouri, Jaber; Al-Asmi, Abdullah; Chentouf, Amina; Inshasi, Jihad; Gouider, Riadh; Mrabet, Saloua; et al. (Multiple Sclerosis Journal, 2024)